Fingolimod phosphate protection against mitochondrial damage in neuronal cells

Universidad de Malaga. Campus de Excelencia Internacional Andalucia Tech. PS13/14: Study of the non-immunological mechanisms of action of Gilenya (Fingolimod) as therapeutic tool in Multiple Sclerosis and/or other neurodegenerative diseases. Novartis Farmaceutica S.A.